Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 11,500
-1,740 (-13.14%)
Jul 21, 2026, 3:30 PM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 601.2 billion as of July 21, 2026. Its market cap has increased by 95.85% in one year.
Market Cap
601.20B
Enterprise Value
544.01B
Revenue
67.20B
Ranking
n/a
PE Ratio
30.02
Stock Price
11,500.00
ChartMarket Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 601.20B, an increase of 221.65%. That is a compound annual growth rate of 109.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 601.20B | -30.88% |
| Dec 30, 2025 | 869.78B | 392.69% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orum Therapeutics | 912.22B |
| Chabiotech | 806.62B |
| Pharmicell | 634.71B |
| GI Innovation | 451.61B |
| Medy-Tox | 446.45B |
| GC Corp. | 421.33B |
| MEDIPOST | 318.55B |
| Genomictree | 293.34B |